Viewing Study NCT06011733


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2026-01-09 @ 6:56 PM
Study NCT ID: NCT06011733
Status: COMPLETED
Last Update Posted: 2025-03-10
First Post: 2023-08-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module